Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1285
mi
from
Boynton Beach, FL
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1285
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1303
mi
from
Plantation, FL
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1303
mi
from
Plantation, FL
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1176
mi
from
Coeur D'alene, ID
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1176
mi
from
Coeur D'alene, ID
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
839
mi
from
Idaho Falls, ID
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
839
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1050
mi
from
Meridian, ID
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1050
mi
from
Meridian, ID
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
428
mi
from
Shreveport, LA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
428
mi
from
Shreveport, LA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1156
mi
from
Annapolis, MD
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1156
mi
from
Annapolis, MD
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
810
mi
from
Ann Arbor, MI
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
810
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
733
mi
from
Grand Rapids, MI
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
733
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
714
mi
from
Kalamazoo, MI
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
714
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
840
mi
from
Royal Oak, MI
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
840
mi
from
Royal Oak, MI
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1236
mi
from
Voorhees, NJ
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1236
mi
from
Voorhees, NJ
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
523
mi
from
Albuquerque, NM
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
523
mi
from
Albuquerque, NM
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1056
mi
from
Brooklyn, NY
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1056
mi
from
Brooklyn, NY
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1303
mi
from
Hyde Park, NY
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1303
mi
from
Hyde Park, NY
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1140
mi
from
Greenville, NC
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1140
mi
from
Greenville, NC
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
970
mi
from
Salisbury, NC
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
970
mi
from
Salisbury, NC
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
971
mi
from
Winston Salem, NC
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
971
mi
from
Winston Salem, NC
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
971
mi
from
Winston-Salem, NC
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
971
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
725
mi
from
Cincinnati, OH
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
725
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
893
mi
from
Cleveland, OH
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
893
mi
from
Cleveland, OH
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
804
mi
from
Tiffin, OH
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
804
mi
from
Tiffin, OH
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
862
mi
from
Zanesville, OH
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
862
mi
from
Zanesville, OH
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1221
mi
from
Bala Cynwyd, PA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1221
mi
from
Bala Cynwyd, PA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1163
mi
from
Lancaster, PA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1163
mi
from
Lancaster, PA
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1098
mi
from
Myrtle Beach, SC
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1098
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
341
mi
from
Dallas, TX
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
341
mi
from
Dallas, TX
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
348
mi
from
Fort Worth, TX
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
348
mi
from
Fort Worth, TX
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
586
mi
from
Houston, TX
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
586
mi
from
Houston, TX
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
342
mi
from
Irving, TX
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
342
mi
from
Irving, TX
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
773
mi
from
Salt Lake City, UT
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
773
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated:  1/3/2014
Afferent Investigative Site
1190
mi
from
Virginia Beach, VA
The Safety and Efficacy of AF-219 in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome
Status: Enrolling
Updated: 1/3/2014
Afferent Investigative Site
1190
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Effect of Exercise and Biofeedback on Symptoms of Incontinence in Women With Stress Urinary Incontinence
Effect of Rehabilitative Ultrasound Imaging Biofeedback on Urinary Incontinence, Pelvic Floor Muscle Contractions and Quality of Life in Women With Stress Urinary Incontinence
Status: Enrolling
Updated:  1/27/2014
Texas Woman's University
348
mi
from
Dallas, TX
Effect of Exercise and Biofeedback on Symptoms of Incontinence in Women With Stress Urinary Incontinence
Effect of Rehabilitative Ultrasound Imaging Biofeedback on Urinary Incontinence, Pelvic Floor Muscle Contractions and Quality of Life in Women With Stress Urinary Incontinence
Status: Enrolling
Updated: 1/27/2014
Texas Woman's University
348
mi
from
Dallas, TX
Click here to add this to my saved trials
Open Label Trial of Nissle 1917
Phase 1 Open Label Trial of Nissle 1917 to Assess Safety and Tolerance in Healthy Adult Volunteers
Status: Enrolling
Updated:  10/27/2014
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Open Label Trial of Nissle 1917
Phase 1 Open Label Trial of Nissle 1917 to Assess Safety and Tolerance in Healthy Adult Volunteers
Status: Enrolling
Updated: 10/27/2014
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Click here to add this to my saved trials
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated:  4/15/2015
GSK Investigational Site
1172
mi
from
Long Beach, CA
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated: 4/15/2015
GSK Investigational Site
1172
mi
from
Long Beach, CA
Click here to add this to my saved trials
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated:  4/15/2015
GSK Investigational Site
898
mi
from
Cleveland, OH
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated: 4/15/2015
GSK Investigational Site
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated:  4/15/2015
GSK Investigational Site
1223
mi
from
Philadelphia, PA
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
See Detailed Description
Status: Enrolling
Updated: 4/15/2015
GSK Investigational Site
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI)
Status: Enrolling
Updated:  4/28/2015
Clinical Research Facility
683
mi
from
Birmingham, AL
Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI)
Status: Enrolling
Updated: 4/28/2015
Clinical Research Facility
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI)
Status: Enrolling
Updated:  4/28/2015
Clinical Research Facility
1444
mi
from
Boston, MA
Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI)
Status: Enrolling
Updated: 4/28/2015
Clinical Research Facility
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI)
Status: Enrolling
Updated:  4/28/2015
Clinical Research Facility
839
mi
from
Royal Oak, MI
Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI)
Status: Enrolling
Updated: 4/28/2015
Clinical Research Facility
839
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI)
Status: Enrolling
Updated:  4/28/2015
Clinical Research Facility
552
mi
from
Minneapolis, MN
Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI)
Status: Enrolling
Updated: 4/28/2015
Clinical Research Facility
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI)
Status: Enrolling
Updated:  4/28/2015
Clinical Research Facility
1256
mi
from
Somers Point, NJ
Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI)
Status: Enrolling
Updated: 4/28/2015
Clinical Research Facility
1256
mi
from
Somers Point, NJ
Click here to add this to my saved trials
Defeating Urinary Incontinence With Exercise Training (DUET) Feasibility Study
Preventing Toileting Disability in Frail Older Women
Status: Enrolling
Updated:  6/11/2015
University of Minnesota, School of Nursing
552
mi
from
Minneapolis, MN
Defeating Urinary Incontinence With Exercise Training (DUET) Feasibility Study
Preventing Toileting Disability in Frail Older Women
Status: Enrolling
Updated: 6/11/2015
University of Minnesota, School of Nursing
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
Status: Enrolling
Updated:  7/11/2015
Beaumont Hospital, Royal Oak
847
mi
from
Royal Oak, MI
Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
Status: Enrolling
Updated: 7/11/2015
Beaumont Hospital, Royal Oak
847
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
Status: Enrolling
Updated:  7/11/2015
William Beaumont Hospital
838
mi
from
Royal Oak, MI
Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
Status: Enrolling
Updated: 7/11/2015
William Beaumont Hospital
838
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Efficacy Study of Adalimumab to Treat Interstitial Cystitis
An Investigator Initiated, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Humira® (Adalimumab) For The Treatment of Interstitial Cystitis(IC)
Status: Enrolling
Updated:  7/12/2015
Philip C. Bosch, MD
1127
mi
from
Escondido, CA
Efficacy Study of Adalimumab to Treat Interstitial Cystitis
An Investigator Initiated, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Humira® (Adalimumab) For The Treatment of Interstitial Cystitis(IC)
Status: Enrolling
Updated: 7/12/2015
Philip C. Bosch, MD
1127
mi
from
Escondido, CA
Click here to add this to my saved trials
Treatment for Stress and Mixed Urinary Incontinence and Vaginal Vault Prolapse
A Prospective Multicenter Clinical Study on a New Approach in Treating Stress and Mixed Incontinence and Vaginal Vault Prolapse
Status: Enrolling
Updated:  7/23/2015
US Surgical
1317
mi
from
Norwalk, CT
Treatment for Stress and Mixed Urinary Incontinence and Vaginal Vault Prolapse
A Prospective Multicenter Clinical Study on a New Approach in Treating Stress and Mixed Incontinence and Vaginal Vault Prolapse
Status: Enrolling
Updated: 7/23/2015
US Surgical
1317
mi
from
Norwalk, CT
Click here to add this to my saved trials
An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence
Muscle Cell Mediated Therapy for Stress Urinary Incontinence: An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells.
Status: Enrolling
Updated:  7/29/2015
Wm Beaumont Hospital
840
mi
from
Royal Oak, MI
An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence
Muscle Cell Mediated Therapy for Stress Urinary Incontinence: An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells.
Status: Enrolling
Updated: 7/29/2015
Wm Beaumont Hospital
840
mi
from
Royal Oak, MI
Click here to add this to my saved trials
An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence
Muscle Cell Mediated Therapy for Stress Urinary Incontinence: An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells.
Status: Enrolling
Updated:  7/29/2015
Vanderbilt University Medical Center
618
mi
from
Nashville, TN
An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence
Muscle Cell Mediated Therapy for Stress Urinary Incontinence: An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells.
Status: Enrolling
Updated: 7/29/2015
Vanderbilt University Medical Center
618
mi
from
Nashville, TN
Click here to add this to my saved trials
An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence
Muscle Cell Mediated Therapy for Stress Urinary Incontinence: An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells.
Status: Enrolling
Updated:  7/29/2015
Sunnybrook Health Sciences Center
1045
mi
from
Toronto,
An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence
Muscle Cell Mediated Therapy for Stress Urinary Incontinence: An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells.
Status: Enrolling
Updated: 7/29/2015
Sunnybrook Health Sciences Center
1045
mi
from
Toronto,
Click here to add this to my saved trials